Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brain Blood Clot Remover Clears FDA; Comparison Found In Stroke Drug Study

This article was originally published in The Gray Sheet

Executive Summary

Concentric Medical averted a randomized clinical trial requirement for Merci Retriever by convincing FDA that a single-arm study backs 510(k) clearance of the embolic retrieval system

You may also be interested in...



FDA Issues Guidance On Trials For Stroke-Treatment Devices

Neurothrombectomy device trials should be designed to show that stroke patients are more likely to have a good outcome with the device than with an established therapy, FDA advises in a June 18 guidance

FDA Issues Guidance On Trials For Stroke-Treatment Devices

Neurothrombectomy device trials should be designed to show that stroke patients are more likely to have a good outcome with the device than with an established therapy, FDA advises in a June 18 guidance

Cyberonics Banking On Appeals To Avoid VNS Randomized Trial Requirement

Cyberonics will defer a new randomized trial of its VNS Therapy depression indication until it can determine whether an appeal of FDA's recent not-approvable decision may be successful

Related Content

UsernamePublicRestriction

Register

MT020751

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel